Psychotropic medication use during pregnancy: changes to the labeling system and the importance of exposure registries

J Clin Psychiatry. 2015 Jul;76(7):990-1. doi: 10.4088/JCP.15ed10163.

Abstract

In this issue of JCP, Cohen et al present the methodology of the National Pregnancy Registry for Atypical Antipsychotics (NPRAA). In full disclosure, the investigators are my colleagues, and I have great interest in the topic of pregnancy registries, including this particular registry, as a perinatal psychiatrist and from a scientific perspective. Highlighting the importance of this paper is intuitive because we are at a defining moment in the application of data to inform the care of pregnant women.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Abnormalities, Drug-Induced / epidemiology*
  • Antipsychotic Agents / therapeutic use*
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications / epidemiology*
  • Pregnancy Outcome / epidemiology*
  • Registries / statistics & numerical data*

Substances

  • Antipsychotic Agents